Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01334541
Other study ID # W81XWH-09-2-0129-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2009
Est. completion date December 2018

Study information

Verified date October 2018
Source VA Eastern Colorado Health Care System
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators propose to evaluate Suicide Assessment and Follow-up Engagement: Veteran Emergency Treatment (SAFE VET) which is currently being implemented in 4 VA ED/Urgent Care Units across the United States (Portland VA Medical Center (VAMC), Denver VAMC, Manhattan VAMC, and Philadelphia VAMC).


Description:

Background: In 2009, a novel clinical demonstration project entitled Suicide Assessment and Follow-up Engagement: Veteran Emergency Treatment (SAFE VET) was initiated as a potential standard of care for suicidal Veterans who receive treatment at Veterans Affairs (VA) emergency departments (ED). SAFE VET is designed to attenuate suicide risk by helping Veterans manage suicidal thoughts and behaviors, and adhere to prescribed clinical care; thereby promoting resiliency and increased capacity to cope with suicidal states.

Objectives: Using a quasi-experimental design, the aim of this study is to compare the effectiveness of the SAFE VET intervention versus enhanced usual care (E-CARE)on the following: 1) the proportion of patients who attempt suicide within 6 months of index emergency department (ED) visit; 2) the severity of suicide ideation within 6 months after index ED visit; 3) the proportion of patients who attend > 1 outpatient mental health or substance abuse treatment appointments within 30 days following index ED visit; and 4) the degree of suicide-related coping for attending treatment during the 6 month period.

Methodology: Six hundred Veterans, up to 300 per condition (SAFE VET or E-CARE), who meet inclusion/exclusion criteria will be enrolled. E-CARE sites are as follows: Long Beach VAMC, Bronx VAMC, Milwaukee VAMC, and San Diego VAMC. All subjects will participate in an approximately 1-hour long baseline assessment battery (index ED visit) by phone, and will be contacted by phone at approximately 1, 3, and 6 months after the index ED visit to complete follow-up measures. Medical records will also be reviewed to determine VA health service usage in the six-month period after study enrollment.


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date December 2018
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria:

Veterans will be enrolled who:

1. have received the SAFE VET intervention in VA SAFE VET EDs or treatment-as-usual in E-CARE EDs;

2. aged 18 years or older;

3. identified as being at risk for suicide based upon presenting complaints and/or the assessment of an ED clinician;

4. able to provide 2 contacts with telephone numbers for tracking purposes; and

5. able to provide a home/residential/shelter address where the participant resides and either a home, cellular, or other telephone number where the participant can be reached.

Exclusion Criteria:

Veterans will not be enrolled if they are:

1. unable to read and understand English;

2. unable or unwilling to give informed consent as determined either by the referring VA ED clinical staff or research personnel (see Mini Quiz below); and/or

3. admitted to the VA inpatient psychiatric unit from the ED.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SAFE VET
All SAFE VET EDs provide a standardized intervention that is specifically adapted for use in the ED to mitigate suicide risk. Given that the SAFE VET intervention was developed for use in a busy ED setting, the length of the intervention is approximately 45 minutes. The SAFE VET intervention is administered by a clinical provider who has been specifically trained and consists of: Risk Assessment Safety Planning Intervention: Developed by Stanley and Brown (2008), Safety Planning Intervention consists of a hierarchically-arranged list of coping strategies identified for use during a subsequent suicidal crisis. Clinical Follow-Up Protocol

Locations

Country Name City State
United States Bronx VAMC Bronx New York
United States Denver VAMC Denver Colorado
United States Long Beach VAMC Long Beach California
United States Manhattan VAMC Manhattan New York
United States Milwaukee VAMC Milwaukee Wisconsin
United States Philadelphia VAMC Philadelphia Pennsylvania
United States Portland VAMC Portland Oregon
United States San Diego VAMC San Diego California

Sponsors (6)

Lead Sponsor Collaborator
VA Eastern Colorado Health Care System Columbia University, Uniformed Services University of the Health Sciences, United States Department of Defense, University of Pennsylvania, US Department of Veterans Affairs

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Columbia Suicide-Severity Rating Scale (C-SSRS; Posner et al., 2006; Posner et al. 2008). Baseline and 1, 3, and 6 month follow-up assessments
Secondary Scale for Suicide Ideation (SSI; Beck, Kovacs, & Weissman, 1979). Baseline and 1, 3, and 6 month follow-up assessments